---
title: "Health Canada authorizes Pfizer-BioNTech XFG-adapted COVID-19 vaccine"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299351665.md"
description: "Health Canada has authorized the Pfizer-BioNTech XFG-adapted Comirnaty COVID-19 vaccine for individuals aged 6 months and older for the 2026-2027 season. This updated mRNA shot targets the Omicron XFG lineage. Doses are expected to be distributed across Canada through multiple channels in the coming days and weeks."
datetime: "2026-09-17T17:30:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299351665.md)
  - [en](https://longbridge.com/en/news/299351665.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299351665.md)
generator: "portal-rs"
---

# Health Canada authorizes Pfizer-BioNTech XFG-adapted COVID-19 vaccine

-   Health Canada authorized Pfizer’s XFG-adapted Comirnaty COVID-19 vaccine for people aged 6 months and older for the 2026-2027 season. \* BioNTech partnered on the updated mRNA shot, which targets the Omicron XFG lineage. \* Doses are expected to roll out across Canada via multiple distribution channels in the coming days and weeks. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pfizer Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202609171330CANADANWCANADAPR\_C8570) on September 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [BNTX.US](https://longbridge.com/en/quote/BNTX.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)

## Related News & Research

- [Can Vaccine Approval Change The Bull Case For BioNTech (BNTX)?](https://longbridge.com/en/news/300368236.md)
- [BioNTech to shutter sites in Germany, Singapore as no buyers emerge](https://longbridge.com/en/news/300309835.md)
- [BioNTech (NasdaqGS:BNTX) Stock May Look Fully Valued On Fresh Lung Cancer Trial Data](https://longbridge.com/en/news/300119736.md)
- [How Investors May Respond To Pfizer (PFE) ESMO Cancer Data Showcase](https://longbridge.com/en/news/300367871.md)
- [BioNTech CEO Uğur Şahin disposes of USD 6,850,514.3 in common shares](https://longbridge.com/en/news/300073568.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**